MARK M. MULLALLY
Publications by Year
Research Areas
Microbial Natural Products and Biosynthesis, Cancer therapeutics and mechanisms, Pharmacogenetics and Drug Metabolism, Enzyme Catalysis and Immobilization, Drug Transport and Resistance Mechanisms
Most-Cited Works
- → 5-N-Acetylardeemin, a novel heterocyclic compound which reverses multiple drug resistance in tumor cells. II. Isolation and elucidation of the structure of 5-N-acetylardeemin and two congeners.(1993)101 cited
- → Discovery and Metabolic Stabilization of Potent and Selective 2-Amino-N-(adamant-2-yl) Acetamide 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors(2006)77 cited
- → MLR-52,(4'-dementhylamino-4',5'-dihydroxystaurosporine), a new inhibitor of protein kinase C with immunosuppressive activity.(1994)41 cited
- → Macquarimicins, Microbial Metabolites from Micromonospora. II. Isolation and Structural Elucidation.(1995)24 cited
- → Dunaimycins, a new complex of spiroketal 24-membered macrolides with immunosuppressive activity. II. Isolation and elucidation of structures.(1991)23 cited
- → ChemInform Abstract: Macquarimicins, Microbial Metabolites from Micromonospora. Part 2. Isolation and Structural Elucidation.(1995)3 cited
- Stop signs on the wireless highway or rear-ended by Rogers: what can a small community stakeholder do?(2010)
- → CCDC 663281: Experimental Crystal Structure Determination(2008)